BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25695330)

  • 21. Autocrine insulin-like growth factor-I signaling promotes growth and survival of human acute myeloid leukemia cells via the phosphoinositide 3-kinase/Akt pathway.
    Doepfner KT; Spertini O; Arcaro A
    Leukemia; 2007 Sep; 21(9):1921-30. PubMed ID: 17581609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential TERT promoter methylation and response to 5-aza-2'-deoxycytidine in acute myeloid leukemia cell lines: TERT expression, telomerase activity, telomere length, and cell death.
    Pettigrew KA; Armstrong RN; Colyer HA; Zhang SD; Rea IM; Jones RE; Baird DM; Mills KI
    Genes Chromosomes Cancer; 2012 Aug; 51(8):768-80. PubMed ID: 22517724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emodin enhances ATRA-induced differentiation and induces apoptosis in acute myeloid leukemia cells.
    Chen Y; Li J; Hu J; Zheng J; Zheng Z; Liu T; Lin Z; Lin M
    Int J Oncol; 2014 Nov; 45(5):2076-84. PubMed ID: 25174432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The protein kinase C agonist prostratin induces differentiation of human myeloid leukemia cells and enhances cellular differentiation by chemotherapeutic agents.
    Shen X; Xiong GL; Jing Y; Xiao H; Cui Y; Zhang YF; Shan YJ; Xing S; Yang M; Liu XL; Dong B; Wang LS; Luo QL; Yu ZY; Cong YW
    Cancer Lett; 2015 Jan; 356(2 Pt B):686-96. PubMed ID: 25449427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of cytosine arabinoside toxicity to the blast cells of acute myeloblastic leukemia: involvement of free radicals.
    Hu ZB; Yang GS; Li M; Miyamoto N; Minden MD; McCulloch EA
    Leukemia; 1995 May; 9(5):789-98. PubMed ID: 7769841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drastic effect of cell density on the cytotoxicity of daunorubicin and cytosine arabinoside.
    Masquelier M; Vitols S
    Biochem Pharmacol; 2004 May; 67(9):1639-46. PubMed ID: 15081863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone marrow stromal cells protect acute myeloid leukemia cells from anti-CD44 therapy partly through regulating PI3K/Akt-p27(Kip1) axis.
    Chen P; Huang H; Wu J; Lu R; Wu Y; Jiang X; Yuan Q; Chen Y
    Mol Carcinog; 2015 Dec; 54(12):1678-85. PubMed ID: 25408361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein kinase CK2alpha as an unfavorable prognostic marker and novel therapeutic target in acute myeloid leukemia.
    Kim JS; Eom JI; Cheong JW; Choi AJ; Lee JK; Yang WI; Min YH
    Clin Cancer Res; 2007 Feb; 13(3):1019-28. PubMed ID: 17289898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of ubenimex (Bestatin) on the cell growth and phenotype of HL-60 and HL-60R cell lines: up-and down-regulation of CD13/aminopeptidase N.
    Imamura N; Kimura A
    Leuk Lymphoma; 2000 May; 37(5-6):663-7. PubMed ID: 11042531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-CD33-antibodies labelled with the alpha-emitter Bismuth-213 kill CD33-positive acute myeloid leukaemia cells specifically by activation of caspases and break radio- and chemoresistance by inhibition of the anti-apoptotic proteins X-linked inhibitor of apoptosis protein and B-cell lymphoma-extra large.
    Friesen C; Roscher M; Hormann I; Leib O; Marx S; Moreno J; Miltner E
    Eur J Cancer; 2013 Jul; 49(11):2542-54. PubMed ID: 23684782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. KML001 displays vascular disrupting properties and irinotecan combined antitumor activities in a murine tumor model.
    Moon CH; Lee SJ; Lee HY; Lee JC; Cha H; Cho WJ; Park JW; Park HJ; Seo J; Lee YH; Song HT; Min YJ
    PLoS One; 2013; 8(1):e53900. PubMed ID: 23326531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
    Hales EC; Taub JW; Matherly LH
    Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knockdown of nucleophosmin by RNA interference reverses multidrug resistance in resistant leukemic HL-60 cells.
    Lin M; Hu J; Liu T; Li J; Chen B; Chen X
    Immunobiology; 2013 Sep; 218(9):1147-54. PubMed ID: 23669237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins.
    Konopleva M; Konoplev S; Hu W; Zaritskey AY; Afanasiev BV; Andreeff M
    Leukemia; 2002 Sep; 16(9):1713-24. PubMed ID: 12200686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disruption of Telomere Integrity and DNA Repair Machineries by KML001 Induces T Cell Senescence, Apoptosis, and Cellular Dysfunctions.
    Cao D; Zhao J; Nguyan LN; Nguyen LNT; Khanal S; Dang X; Schank M; Chand Thakuri BK; Wu XY; Morrison ZD; El Gazzar M; Zou Y; Ning S; Wang L; Moorman JP; Yao ZQ
    Front Immunol; 2019; 10():1152. PubMed ID: 31191531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The non-steroidal anti-inflammatory drugs Sulindac sulfide and Diclofenac induce apoptosis and differentiation in human acute myeloid leukemia cells through an AP-1 dependent pathway.
    Singh R; Cadeddu RP; Fröbel J; Wilk CM; Bruns I; Zerbini LF; Prenzel T; Hartwig S; Brünnert D; Schroeder T; Lehr S; Haas R; Czibere A
    Apoptosis; 2011 Sep; 16(9):889-901. PubMed ID: 21739277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oroxylin A, a natural compound, mitigates the negative effects of TNFα-treated acute myelogenous leukemia cells.
    Li H; Lu N; Yu X; Liu X; Hu P; Zhu Y; Shen L; Xu J; Li Z; Guo Q; Hui H
    Carcinogenesis; 2018 Oct; 39(10):1292-1303. PubMed ID: 29346508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracellular metabolism of Ara-C and resulting DNA fragmentation and apoptosis of human AML HL-60 cells possessing disparate levels of Bcl-2 protein.
    Bullock G; Ray S; Reed JC; Krajewski S; Ibrado AM; Huang Y; Bhalla K
    Leukemia; 1996 Nov; 10(11):1731-40. PubMed ID: 8892676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. KML001, a telomere-targeting drug, sensitizes glioblastoma cells to temozolomide chemotherapy and radiotherapy through DNA damage and apoptosis.
    Woo SR; Ham Y; Kang W; Yang H; Kim S; Jin J; Joo KM; Nam DH
    Biomed Res Int; 2014; 2014():747415. PubMed ID: 25295271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hispolon induces apoptosis through JNK1/2-mediated activation of a caspase-8, -9, and -3-dependent pathway in acute myeloid leukemia (AML) cells and inhibits AML xenograft tumor growth in vivo.
    Hsiao PC; Hsieh YH; Chow JM; Yang SF; Hsiao M; Hua KT; Lin CH; Chen HY; Chien MH
    J Agric Food Chem; 2013 Oct; 61(42):10063-73. PubMed ID: 24093560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.